Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr appears to be leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the emergency contraceptive Plan B (levonorgestrel)